The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease.
about
Oral pathology in inflammatory bowel diseaseThe Gut Microbiota in Immune-Mediated Inflammatory DiseasesInflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features.The Prevalence and Incidence of Axial and Peripheral Spondyloarthritis in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.Periodontal manifestations of inflammatory bowel disease: emerging epidemiologic and biologic evidence.Intestinal Behçet and Crohn's disease: two sides of the same coin.Hospital costs, length of stay and prevalence of hip and knee arthroplasty in patients with inflammatory bowel diseaseThe safety of non-biological treatments in Ulcerative Colitis.The biologics of ulcerative colitis.Crohn's disease diagnosis, treatment approach, and management paradigm: what the radiologist needs to know.Clinical Signs, Pathophysiology and Management of Cutaneous Side Effects of Anti-Tumor Necrosis Factor Agents.Inflammatory Bowel Disease in Childhood and Adolescence.Management of patients with inflammatory bowel disease and spondyloarthritis.Prevalence of Restless Legs Syndrome in Patients with Inflammatory Bowel Disease.Ophthalmic manifestations in patients with inflammatory bowel disease: A reviewPancreatic Involvement in Pediatric Inflammatory Bowel Disease.Skin Manifestations of Inflammatory Bowel Disease.Comparison of Clinical Features between Pyoderma Gangrenosum Concomitant by Inflammatory Bowel Disease and Idiopathic Pyoderma Gangrenosum.Inflammation and Aortic Stiffness: An Individual Participant Data Meta-Analysis in Patients With Inflammatory Bowel Disease.Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohort.Hyperbaric oxygen therapy for pyoderma gangrenosum associated with ulcerative colitis.Acute Coronary Syndrome in Patients With Inflammatory Bowel Diseases: The Plaque and the Thrombus.Steroid but not biological therapy elevates the risk of venous thromboembolic events in inflammatory bowel disease. A meta-analysis.Paradoxical arthritis occurring during anti-TNF in patients with inflammatory bowel disease: histological and immunological features of a complex synovitis.Adalimumab Reduces Extraintestinal Manifestations in Patients with Crohn's Disease: A Pooled Analysis of 11 Clinical Studies.Orbital Inflammatory Complications of Crohn's Disease: A Rare Case Series.Impaired Coagulation Status in the Crohn's Disease Patients Complicated with Intestinal Fistula.Successful treatment of oral Crohn's disease by anti-TNF-alpha dose escalation - a case report.Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease.Obesity in Inflammatory Bowel Disease: Gains in Adiposity despite High Prevalence of Myopenia and Osteopenia
P2860
Q26739055-3CA63236-A2DD-45DE-807D-EFD26977128EQ26741414-35973AA0-247E-4BAA-B3E6-3D971D0960F7Q30234950-7DEBE975-B3A1-4EB5-BC09-2E5ED853B0DFQ30241784-5B8B592E-0ECC-49AB-B405-355198BC96D5Q30245122-7ECBF902-DC39-48F4-A945-45CB657F9E3DQ33582640-1F19A05F-06B8-47C0-BA6F-6468C7D78476Q38647854-7672EA42-98CB-4235-B413-DAF9E27EDF1CQ38728164-ABEE2C79-3C6E-4947-B6BE-C79B073D66C8Q39037681-9BE316D7-4471-4404-9714-223BCE8256EEQ39140194-DDE7A924-5730-4856-9CE8-ED874A1692F4Q39361308-183751DB-37CD-433E-B447-A3A03DD06B38Q39361742-0CB00792-DDA9-415D-BE21-D55D50EB7D34Q40054186-F24BD70D-6068-4B69-AE5A-C0E2DE80521AQ40402171-6D74F3DA-351A-4310-98C6-146A8CEC8B07Q41608459-DE00592C-C060-4A58-8435-4BF95BC00EB2Q42700277-90C1169E-6F4B-44B4-AEA2-19C3B3D39E5EQ44390503-987307D5-63F9-4583-80D0-4A0D84AB3570Q47122895-34C64396-BDFF-4270-A2EA-D67D39C4EC8CQ47142203-9E96DC0B-7335-40ED-9419-55E87D9DCDAFQ48102896-73C50785-DE0E-4525-939F-5F53FB4B9CF1Q49219889-053F4684-CD8A-4FA1-9851-291A5987896EQ49687500-B0C6FC31-CE27-40A7-A284-897FEF2DCB6AQ50003119-BC43F37C-4B0B-4D2C-B6AE-3034A7A08487Q52320824-05219E30-DCE7-4EAF-AB2A-B13DAAFC2EE1Q53838959-979B36A6-846A-438B-8B06-074F57E4733EQ54263616-395CAA60-E9D7-42C6-993C-522A010CD040Q55100475-E4B2784C-C032-4F5A-B8E5-0A7C37D24359Q55317852-2C003F2C-12DE-44DE-BC0D-E8A8E62E6336Q55441867-DD8CCAA9-8C14-4FDF-8644-55C03482E6BBQ58773411-82616358-129C-484C-A5D9-B9CDB2405BB6
P2860
The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
The First European Evidence-ba ...... in Inflammatory Bowel Disease.
@en
The First European Evidence-ba ...... in Inflammatory Bowel Disease.
@nl
type
label
The First European Evidence-ba ...... in Inflammatory Bowel Disease.
@en
The First European Evidence-ba ...... in Inflammatory Bowel Disease.
@nl
prefLabel
The First European Evidence-ba ...... in Inflammatory Bowel Disease.
@en
The First European Evidence-ba ...... in Inflammatory Bowel Disease.
@nl
P2093
P356
P1476
The First European Evidence-ba ...... in Inflammatory Bowel Disease.
@en
P2093
Andrew D Dick
Anne-Marie De Vries
Diamant Thaci
European Crohn’s and Colitis Organisation
Franck Carbonnel
Herbert Tilg
Ioannis Koutroubakis
Kirsten Muri Boberg
Manuel Barreiro-de Acosta
Marcus Harbord
P304
P356
10.1093/ECCO-JCC/JJV213
P577
2015-11-27T00:00:00Z